Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

BACKGROUND: Breast cancer becomes lethal when visceral metastases develop. At this stage, anti-cancer treatments aim at relieving symptoms and delaying death without resulting in additional toxicity. On the basis of their differential anti-oxidant defence level, tumour cells can be made more sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bougnoux, P, Hajjaji, N, Ferrasson, M N, Giraudeau, B, Couet, C, Le Floch, O
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779856/
https://www.ncbi.nlm.nih.gov/pubmed/19920822
http://dx.doi.org/10.1038/sj.bjc.6605441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779856/
https://www.ncbi.nlm.nih.gov/pubmed/19920822
http://dx.doi.org/10.1038/sj.bjc.6605441

Ejemplares similares